Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | SH2D2A |
Upstream (Parents) |
---|
(<<) ACTA2 → SH2D2A |
(<<) ADCY7 → SH2D2A |
(<<) ARHGAP25 → SH2D2A |
(<<) CD274 → SH2D2A |
(<<) CD4 → SH2D2A |
(<<) CORO1A → SH2D2A |
(<<) CRLF3 → SH2D2A |
(<<) EDNRA → SH2D2A |
(<<) GRN → SH2D2A |
(<<) HLA-F → SH2D2A |
(<<) HLA-G → SH2D2A |
(<<) IRF1 → SH2D2A |
(<<) ISG20 → SH2D2A |
(<<) ITGB7 → SH2D2A |
(<<) MLKL → SH2D2A |
(<<) NFKB1 → SH2D2A |
(<<) PIK3CD → SH2D2A |
(<<) PIK3R5 → SH2D2A |
(<<) PLCG2 → SH2D2A |
(<<) PSTPIP1 → SH2D2A |
(<<) RHOG → SH2D2A |
(<<) STAT4 → SH2D2A |
(<<) TRAF1 → SH2D2A |
(<<) ZBED2 → SH2D2A |
Downstream (Children) |
---|
SH2D2A → ASB2 (>>) |
SH2D2A → CABC1 (>>) |
SH2D2A → COL13A1 (>>) |
SH2D2A → DOCK9 (>>) |
SH2D2A → DUSP2 (>>) |
SH2D2A → ENTPD7 (>>) |
SH2D2A → FCRLB (>>) |
SH2D2A → HMGCR (>>) |
SH2D2A → IGFBP2 (>>) |
SH2D2A → IL1R2 (>>) |
SH2D2A → MMP25 (>>) |
SH2D2A → MPP1 (>>) |
SH2D2A → NOS3 (>>) |
SH2D2A → SPRY2 (>>) |
SH2D2A → TNFAIP3 (>>) |